Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
Background Growth differentiation factor‐15 (GDF‐15) has emerged as a novel biomarker to predict all‐cause death in community‐dwelling individuals and patients with cardiovascular disease. We evaluated the prognostic value of GDF‐15 in outpatients with cardiovascular risk factors. Methods and Result...
Main Authors: | Keita Negishi, Satoshi Hoshide, Masahisa Shimpo, Hiroshi Kanegae, Kazuomi Kario |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.022601 |
Similar Items
-
Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
by: Shuai Zheng, et al.
Published: (2023-04-01) -
Impact of home blood pressure variability on cardiovascular outcome in patients with arterial stiffness: Results of the J‐HOP study
by: Yusuke Ishiyama, et al.
Published: (2021-08-01) -
Maternal levels of growth differentiation factor-15 in patients with preeclampsia
by: Ilkbal Temel Yuksel, et al.
Published: (2018-10-01) -
Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
by: Jingru Cheng, et al.
Published: (2023-03-01) -
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
by: Andrea Galassi, et al.
Published: (2022-12-01)